BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics

Chest

Volumn 109, Issue 2, 1996, Pages 338-342

  Aizawa, Hisamichi ^a   Shigyo, Mutsumi ^a   Nogami, Hiroko ^b   Hirose, Takahito ^b   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

astograph; bronchial asthma; methacholine; thromboxane A2

Indexed keywords

METHACHOLINE; PLACEBO; RAMATROBAN; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LUNG RESISTANCE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030060019     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.2.338     Document Type: Article

References (33)

1. National Asthma Education Program. Guidelines for the diagnosis and management of asthma. Washington, DC: US Dept of Health and Human Service, National Institutes of Health
2. 2 and prostacyclin. Pharmacol Rev 1979; 30:293-331
3. Aizawa H, Chung KF, Leikauf GD, et al. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59:1918-23
4. Jones GL, Saroea HG, Watson RM, et al. Effect of an inhaled thromboxane mimetic (U-46619) on airway function in human subjects. Am Rev Respir Dis 1992; 145:1270-74
5. Chung KF, Aizawa H, Becker AB, et al. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY 046) in allergic dogs. Am Rev Respir Dis 1986; 134:258-61
6. Rosentreter U, Boshagen H, Seuter F, et al. Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-Fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid and comparison with its enantiomer. Arzneim-Forsch/Drug Res 1989; 39:1519-21
7. 2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol 1991; 104:585-90
8. Norel X, Labat C, Gardiner PJ, et al. Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations. Br J Pharmacol 1991; 104:591-95
9. 2-induced bronchoconstriction in guinea-pig. Br J Pharmacol 1991; 104:596-602
10. Takishima T, Hida W, Sasaki H, et al. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981; 80:600-06
11. Ishii M, Hida W, Suzuki S, et al. Comparison of intermittent and continuous inhalation provocation tests. Ann Allergy 1989; 62:223-28
12. Mitsuhashi M, Tajima K, Tokuyama K, et al. Application of a new direct-writing recorder device, the 'astograph' to the evaluation of methacholine-induced bronchoconstriction in asthmatic children. J Asthma 1984; 21:89-95
13. Mochizuki H, Mitsuhashi M, Shigeta M, et al. Bronchial hyperresponsiveness in children with atopic and nonatopic asthma. J Asthma 1987; 24:75-80
14. Okayama M, Yafuso N, Nogami H, et al. A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. J Allergy Clin Immunol 1987; 80:291-99
15. Boushey HA, Holtzman MJ, Sheller JR, et al. Bronchial hyperreactivity. Am Rev Respir Dis 1980; 121:389-414
16. Holgate ST, Beasley R, Twentymen OP. The pathogenesis and significance of bronchial hyperresponsiveness in airway disease. Cli Sci 1987; 73:561-72
17. Makino S. Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma. J Allergy 1966; 38:127-42
18. Townley RG, Ryo UY, Kolotkin BM, et al. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975; 56:429-42
19. Spector SL, Farr RS. A comparison of methacholine and histamine inhalations in asthmatics. J Allergy Clin Immunol 1975; 56:308-16
20. Cockroft DW. Airway hyperresponsiveness: therapeutic implications. Ann Allergy 1987; 59:405-14
21. Hamberg M, Svensson J, Wakabayashi T, et al. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 1974; 71:345-49
22. 2: effects on airway and vascular smooth muscle. Prostaglandins 1977; 14:425-36
23. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72:2994-98
24. Higgs GA, Moncada S, Salmon JA, et al. The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol 1983; 79:863-68
25. 4 induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59:1941-46
26. Chung KF, Aizawa H, Leikauf GD, et al. Airway hyperresponsiveness induced by platelet activating factor: role of thromboxane generation. J Pharmacol Exp Ther 1986; 236:580-84
27. Chung KF, Evans TW, Graf PD, et al. Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U 46619. Eur J Pharmacol 1985; 117:373-75
28. 2 in canine airway smooth muscle. J Appl Physiol 1987; 63:1396-1400
29. 1α and β-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. Br J Clin Pharmacol 1985; 19:459-70
30. Seltzer J, Bigby BG, Stulbarg M, et al. Ozone-induced changes in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986; 60:1321-26
31. Kirby JG, Hargreave FE, Cockroft DW, et al. The effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 1989; 66:578-83
32. Fujimura M, Sasaki F, Nakatsumi Y, et al. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986; 41:955-59
33. 2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. Br J Clin Pharmacol 1992; 34:402-08